Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains

Microbial Drug Resistance

Volumn 18, Issue 3, 2012, Pages 322-332

  Proença, Daniela ^a   Fernandes, Sofia ^a,b   Leandro, Clara ^a   Silva, Filipa Antunes ^a   Santos, Sofia ^c,d   Lopes, Fátima ^c,d   Mato, Rosario ^d,e   Cavaco Silva, Patrícia ^a,f   Pimentel, Madalena ^b   São José, Carlos ^b,g  

^a Technophage SA   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA   (Portugal)

^d INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^e UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^f INSTITUTO SUPERIOR DE CIÊNCIAS DA SAÚDE EGAS MONIZ   (Portugal)

^g INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; ANTIINFECTIVE AGENT; CYSTEINE; ENDOLYSIN 168; ENDOLYSIN 170; HISTIDINE; PEPTIDASE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATE; CELL WALL; CHIMERA; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; MOLECULAR CLONING; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AMIDOHYDROLASES; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; CELL WALL; CLONING, MOLECULAR; ENTEROCOCCUS FAECALIS; HOST SPECIFICITY; MOLECULAR SEQUENCE DATA; PEPTIDOGLYCAN; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; STAPHYLOCOCCUS PHAGES; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL PROTEINS;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; STAPHYLOCOCCUS AUREUS;

EID: 84862018596     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2012.0024     Document Type: Article

References (53)

1. Altschul, S.F., T.L. Madden, A.A. Schäffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Bateman, A., and N.D. Rawlings. 2003. The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends. Biochem. Sci. 28:234-237.
3. Besemer, J., and M. Borodovsky. 2005. GeneMark: web software for gene finding in prokaryotes, eukaryotes and viruses. Nucleic Acids Res. 33(Web Server issue):W451-W454.
4. Cheng, X., X. Zhang, J.W. Pflugrath, and F.W. Studier. 1994. The structure of bacteriophage T7 lysozyme, a zinc amidase and an inhibitor of T7 RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 91:4034-4038.
5. Chung, C.T., S.L. Niemela, and R.H. Miller. 1989. One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci. U. S. A. 86:2172-2175.
6. Clokie, M., and A. Kropinski. 2009. Bacteriophages: Methods and Protocols, 1st edition. Humana Press, New York.
7. Depardieu, F., B. Perichon, and P. Courvalin. 2004. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. J. Clin. Microbiol. 42:5857-5860.
8. Ebina, T., H. Toh, and Y. Kuroda. 2009. Loop-length dependent SVM prediction of domain linkers for high-throughput structural proteomics. Biopolymers 92:1-8.
9. Emori, T.G., and R.P. Gaynes. 1993. An overview of nosocomial infections, including the role of the microbiology laboratory. J. Clin. Microbiol. 6:428-442.
10. Fenton, M., P., Ross, O. McAuliffe, J. O'Mahoney, and A. Coffey. 2010. Recombinant bacteriophages lysins as anti-bacterials. Bioeng. Bugs 1:9-16.
11. Fernandes, S., D. Proença, C. Cantante, F.A. Silva, C. Leandro, S. Lourenço, M. Pimentel, H. de Lencastre, P. Cavaco-Silva, M. Garcia, and C. São-José. 2012. Novel chimerical endolysins with broad antimicrobial activity against Methicillin-Resistant Staphylococcus aureus. Microb. Drug. Resist. 18:333-343. MDR, Great Wall Symposium- 2011.
12. Fischetti, V.A. 2008. Bacteriophage lysins as effective anti-bacterials. Curr. Opin. Microbiol. 11:393-400.
13. Fischetti, V.A. 2010. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. Int. J. Med. Microbiol. 300:357-362.
14. Fisher, K., and C., Philips. 2009. The ecology, epidemiology and virulence of Enterococcus. Microbiology 155:1749-1757.
15. French, G.L. 2010. The continuing crisis in antibiotic resistance. Int. J. Antimicrob. Agents 3:S3-S7.
16. Huycke, M.M., C.A. Spiegel, and M.S. Gilmore. 1991. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 35:1626-1634.
17. Jackson, C.R., P.J. Fedorka-Cray, and J.B. Barrett. 2004. Use of a genus- and species-specific multiplex PCR for identification of enterococci. J. Clin. Microbiol. 42:3558-3565.
18. Kutter, E. and A. Sulakvelidze. 2004. Bacteriophages: Biology and Applications, 1st edition. CRC Press, Boca Raton.
19. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
20. Larkin, M.A. et al. 2007. ClustalW and ClustalX version 2 (2007) Bioinformatics 23:2947-2948.
21. Layec, S., B. Decaris, and N. Leblond-Bourget. 2008. Characterization of proteins belonging to the CHAP-related superfamily within the Firmicutes. J. Mol. Microbiol. Biotechnol. 14:31-40.
22. Layec, S., B. Decaris, and N. Leblond-Bourget. 2008. Diversity of Firmicutes peptidoglycan hydrolases and specificities of those involved in daughter cell separation. Res. Microbiol. 159:507-515.
23. Loessner, M.J. 2005. Bacteriophage endolysins-current state of research and applications. Curr. Opin. Microbiol. 8: 480-487.
24. López, R., and E. García. 2004. Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol. Rev. 28:553-580.
25. Low, L.Y., C. Yang, M. Perego, A. Osterman, and R. Liddington. 2011. Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins. J. Biol. Chem. 286:34391-34403.
26. Marchler-Bauer, A. et al. 2011. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res. 39:D225-D229.
27. Mato, R., F. Almeida, R. Pires, P. Rodrigues, T. Ferreira, and I. Santos-Sanches. 2009. Assessment of high-level gentamicin and glycopeptide-resistant Enterococcus faecalis and E. faecium clonal structure in a Portuguese hospital over a 3-year period. Eur. J. Clin. Microbiol. Infect. Dis. 28:855-859.
28. Navarre, W.W., H. Ton-That, K.F. Faull, and O. Schneewind. 1999. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage φ11. Identification of a D-alanyl-glycine endopeptidase activity. J. Biol. Chem. 274:15847-15856.
29. Noguchi, H., T. Taniguchi, and T. Itoh T. 2008. MetaGene Annotator: detecting species-specific patterns of ribosomal binding site for precise gene prediction in anonymous prokaryotic and phage genomes. DNA Res. 15:387-396.
30. O'Flaherty, S., R.P. Ross, and A. Coffey. 2009. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol. Rev. 33:801-819.
31. Paulsen, I.T., et al. 2003. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299:2071-2074.
32. Poh, C.H., H.M.L. Oh, and A.L. Tan. 2006. Epidemiology and clinical outcome of enterococcal bacterium in an acute care hospital. J. Infect. 52:383-386.
33. Pritchard, D.G., S. Dong, J.R. Baker, and J.A. Engler. 2004. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 150:2079-2087.
34. Rashel, M., J. Uchiyama, I. Takemura, H. Hoshiba, T. Ujihara, H. Takatsuji, K. Honke, and S. Matsuzaki. 2008. Tail-associated structural protein gp61 of Staphylococcus aureus phage φMR11 has bifunctional lytic activity. FEMS Microbiol. Lett. 284:9-16.
35. Rigden, D.J., M.J. Jedrzejas, and M.Y. Galperin. 2003. Amidase domains from bacterial and phage autolysins define a family of gamma-D,L-glutamate- specific amidohydrolases. Trends Biochem. Sci. 28:230-234.
36. Rodríguez, L., B. Martínez, Y. Zhou, A. Rodríguez, D.M. Donovan, and P. García. 2011. Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB-SauS-phiIPLA88. BMC Microbiol. 11:138.
37. Rossolini, G.M., E. Mantengoli, F.Montagnani, and S. Pollini. 2010. Epidemiology and clinical relevance of microbial resistance determinants versus anti-Gram-positive agents. Curr. Opin. Microbiol. 13:582-588.
38. Sahm, D.F., J. Kissinger, M.S. Gilmore, P.R. Murray, R. Mulder, J. Solliday, and B. Clarke. 1989. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 33:1588-1591.
39. Sambrook, J., and D.W. Russell. 2001. Molecular Cloning: A Laboratory Manual, 3rd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
40. São-José, C., J. Nascimento, R. Parreira, and M.A. Santos. 2007. Release of progeny phages from infected cells. In S. Macgrath and D. van Sinderen (eds.), Bacteriophages: Genetics and Molecular Biology. Horizon Scientific Press and Caister Academic Press, Norwich, U.K., pp. 309-336.
41. São-José, C., R. Parreira, G. Vieira, and M.A. Santos. 2000. The N-terminal region of the Oenococcus oeni bacteriophage fOg44 lysin behaves as a bona fide signal peptide in Escherichia coli and as a cis-inhibitory element, preventing lytic activity on oenococcal cells. J. Bacteriol. 182:5823-5831.
42. Sava, I.G., E. Heikens, and J. Huebner. 2010. Pathogenesis and immunity in enterococcal infections. Clin. Microbiol. Infect. 16:533-540.
43. Schaberg, D.R., D.H. Culver, and R.P. Gaynes. 1991. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 91:72s-75s.
44. Schleifer, K.H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36:407-477.
45. Shankar, V., A.S. Baghdayan, M.M. Huycke, G. Lindahl, M.S. Gilmore. 1999. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect. Immun. 67:193-200.
46. Son, J.S., S.Y. Jun, E.B. Kim, J.E. Park, H.R. Paik, S.J. Yoon, S.H. Kang, and Y.J. Choi. 2010. Complete genome sequence of a newly isolated lytic bacteriophage, EFAP-1 of Enterococcus faecalis, and antibacterial activity of its endolysin EFAL-1. J. Appl. Microbiol. 108:1769-1779.
47. Uchiyama, J., M. Rashel, I. Takemura, H. Wakiguchi, and S. Matsuzaki. 2008. In silico and in vivo evaluation of bacteriophage φEF24C, a candidate for treatment of Enterococcus faecalis infections. Appl. Environ. Microbiol. 74: 4149-4163.
48. Uchiyama, J., I. Takemura, I. Hayashi, S. Matsuzaki, M. Satoh, T. Ujihara, M. Murakami, M. Imajoh, M. Sugai, and M. Daibata. 2011. Characterization of lytic enzyme open reading frame 9 (ORF9) derived from Enterococcus faecalis bacteriophage φEF24C. Appl. Environ. Microbiol. 77: 580-585.
49. Vinga, I., C. Baptista, I. Auzat, I. Petipas, R. Lurz, P. Tavares, M.A. Santos, and C. São-José. 2012. Role of bacteriophage SPP1 tail spike protein gp21 on host cell receptor binding and trigger of phage DNA ejection. Mol. Microbiol. 83:289-303.
50. Yasmin, A., J.G. Kenny, J. Shankar, A.C. Darby, N. Hall, C. Edwards, and M.J. Horsburgh. 2010. Comparative genomics and transduction potential of Enterococcus faecalis temperate bacteriophages. J. Bacteriol. 192:1122-1130.
51. Yoong, P., R. Schuch, D. Nelson, and V.A. Fischetti. 2004. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J. Bacteriol. 186:4808-4812.
52. Zhang, Z., S. Schwartz, L. Wagner, and W. Miller. 2000. A greedy algorithm for aligning DNA sequences. J. Comput. Biol. 7:203-214.
53. Zou, Y., and C. Hou. 2010. Systematic analysis of an amidase domain CHAP in 12 Staphylococcus aureus genomes and 44 staphylococcal phage genomes. Comput. Biol. Chem. 34: 251-257.